Integrating Amniotic Membranes Into Practice
Drs. Feulner, Milner, and Ayres explain when, why, and how to use amniotic membranes to promote regenerative healing, improve surgical outcomes, and expand treatment options for ocular surface disease.
Clinical Scorecard: Integrating Amniotic Membranes Into Practice
At a Glance
Category Detail
Condition Ocular surface disease Key Mechanisms Regenerative healing, anti-angiogenesis, anti-scarring Target Population Patients with corneal ulcers, neurotrophic keratitis, and those undergoing epithelial keratectomy Care Setting Ophthalmology practices, including cornea specialty clinics
Key Highlights
Amniotic membranes promote healing and reduce discomfort post-surgery. Different types of amniotic membranes (cryopreserved, dried) are available for various patient needs. Utilizing amniotic membranes can improve surgical outcomes and patient satisfaction. Preoperative treatment of corneal disease can enhance results of cataract surgery. Emerging options include amniotic drops and umbilical cord tissue. Guideline-Based Recommendations
Diagnosis
Identify patients with corneal ulcers, neurotrophic keratitis, and epithelial keratectomy candidates. Management
Use amniotic membranes to enhance healing and minimize scarring in ocular surface procedures. Monitoring & Follow-up
Assess healing progress and patient comfort post-application of amniotic membranes. Risks
Potential discomfort from thermoplastic rings in cryopreserved membranes. Patient & Prescribing Data
Patients with ocular surface diseases requiring surgical intervention.
Both cryopreserved and dried amniotic membranes can be effective; choice depends on patient comfort and specific clinical scenarios.
Clinical Best Practices
Familiarize with one type of amniotic membrane and technique before expanding to others. Consider preoperative treatment for patients with corneal surface changes to improve surgical outcomes. References
